Predictive Oncology (NASDAQ:POAI) vs. Mitesco (OTCMKTS:MITI) Head-To-Head Survey

Predictive Oncology (NASDAQ:POAI) and Mitesco (OTCMKTS:MITI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Profitability

This table compares Predictive Oncology and Mitesco’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Predictive Oncology	-5,065.23%	-732.73%	-235.55%
Mitesco	-7,638.20%	N/A	-2,270.77%

Institutional & Insider Ownership

9.0% of Predictive Oncology shares are owned by institutional investors. Comparatively, 0.0% of Mitesco shares are owned by institutional investors. 1.2% of Predictive Oncology shares are owned by company insiders. Comparatively, 4.9% of Mitesco shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Predictive Oncology and Mitesco”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Predictive Oncology	$1.66 million	4.69	-$12.66 million	($13.50)	-0.17
Mitesco	$40,000.00	42.82	-$2.51 million	($0.14)	-0.71

Mitesco has lower revenue, but higher earnings than Predictive Oncology. Mitesco is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Predictive Oncology has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, Mitesco has a beta of 5.56, indicating that its share price is 456% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current recommendations for Predictive Oncology and Mitesco, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Predictive Oncology	1	0	0	0	1.00
Mitesco	0	0	0	0	0.00

About Predictive Oncology

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.

About Mitesco

Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.